JPH03106887A - Optically active alcohols and production thereof - Google Patents
Optically active alcohols and production thereofInfo
- Publication number
- JPH03106887A JPH03106887A JP1245956A JP24595689A JPH03106887A JP H03106887 A JPH03106887 A JP H03106887A JP 1245956 A JP1245956 A JP 1245956A JP 24595689 A JP24595689 A JP 24595689A JP H03106887 A JPH03106887 A JP H03106887A
- Authority
- JP
- Japan
- Prior art keywords
- group
- substituted
- compound
- optically active
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 150000001298 alcohols Chemical class 0.000 title description 7
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 claims abstract description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 14
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 abstract description 44
- -1 (substituted) phenyl Chemical group 0.000 abstract description 41
- 239000013543 active substance Substances 0.000 abstract description 9
- 230000015572 biosynthetic process Effects 0.000 abstract description 7
- 230000003647 oxidation Effects 0.000 abstract description 7
- 238000007254 oxidation reaction Methods 0.000 abstract description 7
- 150000003180 prostaglandins Chemical class 0.000 abstract description 7
- 238000003786 synthesis reaction Methods 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 6
- 229940094443 oxytocics prostaglandins Drugs 0.000 abstract description 5
- 238000006859 Swern oxidation reaction Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 45
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 26
- 239000000243 solution Substances 0.000 description 19
- 238000006243 chemical reaction Methods 0.000 description 18
- XXROGKLTLUQVRX-UHFFFAOYSA-N hydroxymethylethylene Natural products OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 13
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 13
- 239000000543 intermediate Substances 0.000 description 10
- 150000004808 allyl alcohols Chemical group 0.000 description 9
- 239000012044 organic layer Substances 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 239000012043 crude product Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 239000004593 Epoxy Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- GGDWDKDPRJFMHD-ZXYUVVQBSA-N methyl 7-[(1r,2r,3r)-3-hydroxy-2-[(e,3r)-3-hydroxy-4-methoxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate Chemical compound CCCCC(C)(OC)[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC GGDWDKDPRJFMHD-ZXYUVVQBSA-N 0.000 description 4
- 229950000086 mexiprostil Drugs 0.000 description 4
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- 239000012038 nucleophile Substances 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- JSPLKZUTYZBBKA-UHFFFAOYSA-N trioxidane Chemical compound OOO JSPLKZUTYZBBKA-UHFFFAOYSA-N 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 3
- 239000012300 argon atmosphere Substances 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 238000005598 Sharpless reaction Methods 0.000 description 2
- CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 description 2
- 150000001336 alkenes Chemical group 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000002524 organometallic group Chemical group 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 2
- 125000004665 trialkylsilyl group Chemical group 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- POILWHVDKZOXJZ-ARJAWSKDSA-M (z)-4-oxopent-2-en-2-olate Chemical compound C\C([O-])=C\C(C)=O POILWHVDKZOXJZ-ARJAWSKDSA-M 0.000 description 1
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 1
- 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- XHCLAFWTIXFWPH-UHFFFAOYSA-N [O-2].[O-2].[O-2].[O-2].[O-2].[V+5].[V+5] Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[V+5].[V+5] XHCLAFWTIXFWPH-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 238000005828 desilylation reaction Methods 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- KZLUHGRPVSRSHI-UHFFFAOYSA-N dimethylmagnesium Chemical compound C[Mg]C KZLUHGRPVSRSHI-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- CCERQOYLJJULMD-UHFFFAOYSA-M magnesium;carbanide;chloride Chemical compound [CH3-].[Mg+2].[Cl-] CCERQOYLJJULMD-UHFFFAOYSA-M 0.000 description 1
- HRDXJKGNWSUIBT-UHFFFAOYSA-N methoxybenzene Chemical group [CH2]OC1=CC=CC=C1 HRDXJKGNWSUIBT-UHFFFAOYSA-N 0.000 description 1
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 1
- 230000002794 monomerizing effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000012434 nucleophilic reagent Substances 0.000 description 1
- KQPMFNHZHBLVRR-UHFFFAOYSA-N oxalic acid;hydrochloride Chemical compound Cl.OC(=O)C(O)=O KQPMFNHZHBLVRR-UHFFFAOYSA-N 0.000 description 1
- 125000003232 p-nitrobenzoyl group Chemical group [N+](=O)([O-])C1=CC=C(C(=O)*)C=C1 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- QPFYXYFORQJZEC-UHFFFAOYSA-N phenazopyridine Chemical compound NC1=NC(N)=CC=C1N=NC1=CC=CC=C1 QPFYXYFORQJZEC-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 description 1
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 125000005031 thiocyano group Chemical group S(C#N)* 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 1
- 229910001935 vanadium oxide Inorganic materials 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Description
【発明の詳細な説明】
産東上生立且允夏
本発明は,それ自体生理活性物質として有用である上、
分子構造中に2級アリルアルコール骨格を含み,かつ、
分子内に連続する2つの不斉中心を有するプロスタグラ
ンジン等の各種生纏活性物質の合成中間体として有用な
γ位にシリル基を有する光学活性アルコール類及びその
保護体並びにそれらの製造方法に関する.
の び が しようとする課
2級アリルアルコールはそれ自体有用な化合物であり、
また、有用な合成中間体として従来より広く認められて
いる.特に、近年分子構造中に2級アリルアルコールの
骨格を含む各種生理活性化合物が広く知られるようにな
っているが、これらの化合物の多くは光学活性体であり
、2級アリルアルコールの光学活性体の合或は工業的に
重要な課題となっている.
特に、最終目的化合物(多くは光学活性なアリルアルコ
ールの骨格をその分子構造中に含み,一層複雑な化合物
及びその立体異性体となっている)の合戒を考えた場合
、これらのものを有利に合威できる中間体として種々の
反応操作が極めて容易に行なえる光学活性を有するアリ
ルアルコールが望まれている.このような光学活性アリ
ルアルコールとして、例えばγ位にハロゲン原子を有す
る下記一般式
1゜ぺ督)/R
二
OH
(但し、Rは炭素数1〜10の置換もしくは未置換のア
ルキル基又は置換もしくは未置換のフェニル基である.
)
で示される光学活性アリルアルコールは、新しい型の医
薬品であるプロスタグランジン系化合物の合威に非常に
重要な合威中間体として知られている(特願昭62−2
38169号).
更に、近年,プロスタグランジンの一種である下記式
は、下記反応式に示すように,ネロールの不斉シャープ
レス反応によって得られるエポキシアルコールから9段
階でγ位にスズを有する2I&アリルアルコールを合威
する方法(N, Kolb等、Tstrahedron
. Lstt., 2 9 . 8 7 e 9 ,(
1988))が知られている.
で示されるメキシプロスチル(Mexiprostil
)のω鎖などに有用な合或中間体して分子内に連続する
2つの不斉中心を有する2級アリルアルコールが望まれ
ている.
従来、メキシプロスチルのω鎖の合成法とじて二
〇S1く
しかし、上記合成方法では不斉シャープレス反応の選択
性が低く、中間体の光学純度が医薬品の中間体としては
不十分なものであり、合成後に煩雑な精製が必要である
という問題があった.本発明は,上記事情に鑑みなされ
たもので.光学純度が高く、それ自体生理活性物質とし
て有用である上、分子内に連続する2つの不斉中心を有
する2級アリルアルコールを分子構造中に骨格として含
むプロスタグランジン等の各種生理活性物質の合成中間
体として有用なγ位にシリル基を有する光学活性アルコ
ール類及びその製造方法を提供することを目的とする.
を するための び
本発明者は、上記目的を達或するため鋭意検討を重ねた
結果、先に本出願人が特願昭63−57017号に提案
した下記一般式
ープレス反応を行なうことによって得られる下記一般式
(V)
及び下記一般式(VI)
(式中、Rt , R@ , R 3は上記と同様であ
る,)で示される光学活性エポキシアルコールは光学純
度が極めて高く,これら光学活性エポキシアルコールを
それぞれ下記反応式
(式中,R″,R”,R”はそれぞれ炭素数1〜10の
置換もしくは未置換のアルキル基又は置換もしくは未置
換のフエニル基で、互いに同一であっても興なっていて
もよい.以下同様.)で示されるジアリルアルコールに
対して不斉シャOH
0x
(I[I)
のように誘導して一般式(Iffl,(fV)の光学活
性アルコールを得,この(m)式又は(mV)式の光学
活性アルコールを蒙化することにより、下記一般式(1
)
又は下記一般式(n)
Ox
OX
(但し R4は炭素数1〜10の置換もしくは未置換の
アルキル基又は置換もしくは未置換のフエニル基であり
、Xは水素原子又は水酸基の保護基である.)
で示される新規なγ位にシリル基を有する光学活性ケト
アルコール及びその保護体を高い光学純度で合成でき、
しかも,これら光学活性ケトアルコール及びその保護体
は、それ自体生理活性物質として有用である上、分子内
に連続する2つの不斉中心を有する2Rアリルアルコー
ルを分子構造中に骨格として含むプロスタグランジン等
の各種生理活性物質の合成中間体として有用であること
を知見し、本発明をなすに至った.
従って、本発明は上記一般式([1又は(n)で示され
るγ位にシリル基を有する光学活性アルコール類、並び
に、上記(m)式又は(mV)式で示される光学活性ア
ルコールを酸化することを特徴とする上記(1)式又は
CIll式で示される光学活性アルコール類の製造方法
を提供する.以下,本発明につき更に詳述する.
本発明の光学活性アルコール類は、下記一般式(1)
0X
及び下記一般式(II)
で示されるγ位にシリル基を有する光学活性ケトアルコ
ール及びその保護体である.
ここで、Rl, R2,R3はそれぞれ炭素数l〜10
の置換もしくは未置換のアルキル基又は置換もしくは未
置換のフェニル基で,具体的には、メチル、エチル、n
−プロビル、i−プロビル、n−ブチル、i−ブチル、
t−ブチル、アミル、ヘキシル、ヘブチル、オクチル、
ノニル、デシル、フェニル、p一トリル、m−クロロフ
ェニル、pーメトキシフェニル等の基を挙げることがで
きる6なお、R1, R2, R3は互いに同一であっ
ても異なっていてもよい。[Detailed Description of the Invention] The present invention is useful as a physiologically active substance in itself, and
contains a secondary allyl alcohol skeleton in its molecular structure, and
Optically active alcohols having a silyl group at the γ-position useful as intermediates for the synthesis of various synthetic active substances such as prostaglandins having two consecutive asymmetric centers in the molecule, protected forms thereof, and methods for their production. .. The section that Nobi is trying to explain is that secondary allyl alcohol is itself a useful compound.
It has also been widely recognized as a useful synthetic intermediate. In particular, in recent years, various physiologically active compounds containing a secondary allyl alcohol skeleton in their molecular structure have become widely known, but many of these compounds are optically active forms, and optically active forms of secondary allyl alcohol. This has become an important issue from an industrial perspective. In particular, when considering the synthesis of the final target compound (many of which contain an optically active allyl alcohol skeleton in their molecular structure, resulting in more complex compounds and their stereoisomers), these compounds are advantageous. Allyl alcohol has optical activity and is desired as an intermediate that can be used in a variety of reactions. As such an optically active allyl alcohol, for example, the following general formula (1゜P)/R2OH having a halogen atom at the γ position (where R is a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or a substituted or unsubstituted alkyl group) is used. It is an unsubstituted phenyl group.
) is known as a very important synthesis intermediate for the synthesis of prostaglandin compounds, which are new types of pharmaceuticals (Patent Application No.
No. 38169). Furthermore, in recent years, as shown in the reaction formula below, which is a type of prostaglandin, 2I and allyl alcohol having tin at the γ position are synthesized in 9 steps from epoxy alcohol obtained by the asymmetric Sharpless reaction of nerol. (N, Kolb et al., Tstrahedron
.. Lstt. , 29. 8 7 e 9 , (
1988)) is known. Mexiprostil (Mexiprostil)
) is desired as a secondary allyl alcohol having two consecutive asymmetric centers in the molecule as a useful intermediate for synthesis such as the ω chain of Conventionally, the synthesis method for the ω chain of mexiprostil was 20S1, but the selectivity of the asymmetric Sharpless reaction was low in the above synthesis method, and the optical purity of the intermediate was insufficient to be used as a pharmaceutical intermediate. However, there was a problem in that complicated purification was required after synthesis. The present invention was made in view of the above circumstances. It has high optical purity and is useful as a physiologically active substance in itself. It is also useful for various physiologically active substances such as prostaglandins, which contain a secondary allyl alcohol with two consecutive asymmetric centers in the molecule as a backbone. The purpose of this invention is to provide optically active alcohols having a silyl group at the γ-position that are useful as synthetic intermediates, and a method for producing the same. In order to achieve the above object, the present inventor has made extensive studies and found that the following general formula, which was previously proposed by the present applicant in Japanese Patent Application No. 63-57017, can be obtained by carrying out a press reaction. The optically active epoxy alcohols represented by the following general formula (V) and the following general formula (VI) (wherein Rt, R@, and R3 are the same as above) have extremely high optical purity; The epoxy alcohol is prepared using the following reaction formula (where R'', R'', and R'' are each a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or a substituted or unsubstituted phenyl group, even if they are the same as each other). An optically active alcohol of the general formula (Iffl, (fV) is obtained by deriving the diallyl alcohol represented by the asymmetric formula OH 0x (I[I) as follows. By monomerizing this optically active alcohol of formula (m) or (mV), the following general formula (1
) or the following general formula (n) Ox OX (where R4 is a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or a substituted or unsubstituted phenyl group, and X is a hydrogen atom or a hydroxyl group protecting group. ) A novel optically active ketoalcohol having a silyl group at the γ-position and its protected form can be synthesized with high optical purity,
Moreover, these optically active keto alcohols and their protected forms are not only useful as physiologically active substances in themselves, but also prostaglandins whose molecular structure contains a 2R allyl alcohol having two consecutive asymmetric centers in the molecule. The present inventors have discovered that this compound is useful as a synthetic intermediate for various physiologically active substances such as, etc., and have accomplished the present invention. Therefore, the present invention provides an optically active alcohol having a silyl group at the γ-position represented by the above general formula ([1 or (n)), and an optically active alcohol represented by the above formula (m) or (mV). Provided is a method for producing optically active alcohols represented by the above formula (1) or CIll formula, characterized in that the present invention is further described in detail below. 0
A substituted or unsubstituted alkyl group or a substituted or unsubstituted phenyl group, specifically methyl, ethyl, n
-provil, i-provil, n-butyl, i-butyl,
t-butyl, amyl, hexyl, hebutyl, octyl,
Examples include groups such as nonyl, decyl, phenyl, p-tolyl, m-chlorophenyl, and p-methoxyphenyl.6 Note that R1, R2, and R3 may be the same or different from each other.
更に、R4は、上述したように、炭素数1〜10の置換
もしくは未置換のアルキル基又は置換もしくは未置換の
フェニル基を示すが、具体的には,メチル、エチル、n
−プロビル,i−プロビル、n−ブチル,i−ブチル、
t−ブチル、アミル、ヘキシル、ヘプチル、オクチル、
ノニル、デシル、2−メチルヘキシル、2−メチル−2
−ヘキシル、2−ヘキシル、シクロペンチル、シクロヘ
キシル、シクロヘキシルメチル、ヘキサー4一イン−2
−イル,ヘブタ−4−イン−2−イル、2.6−ジメチ
ルーへブタ−5−エンー1−イル、ペンター1−エンー
1−イル、ペンター2−エンー1−イル、ヘキサー1−
エンー2−イル、3−エトキシ−2−メチループロパン
−2−イル、エトキシエチル,5−メトキシヘキシル、
6−メトキシ−2−ヘキシル,ハロゲン化メチル、ハロ
ゲン化n−ブチル,ハロゲン化n−ペンチル、ハロゲン
化ノニル、フェニル、ベンジル、ハロゲン化フェニル、
n−ペンチルオキシメチル,1−エトキシ−2−メチル
ープロパン−2−イル、フェノキシメチル,ペンジロキ
シメチル、p−クロルーフエノキシメチル、2−フェニ
ルエチル、ペンジロキシエチル,p−フルオローフエノ
キシメチル、フェニルアセチレニル、m−クロルーフェ
ノキシメチル.m−トリフルオロメチルーフエノキシメ
チル、l−ブチルーシクロプロビル、3−エチルーシク
ロペンチル,ペンゾチオフェン−5−イル,2−オクテ
ニル、3−メトキシカルボニルプロビル,ビニル等の基
を挙げることができる.また、Xは水素原子又は水酸基
の保護基であり、水酸基の保護基としては、例えばトリ
アルキルシリル基(例えばトリメチルシリル基,t−ブ
チルジメチルシリル基,フェニルジメチルシリル基)、
アルコキシアルキル基(例えばメトキシメチル基,エト
キシエチル基2テトラヒド口ピラニル基),アラルキル
オキシアルキル基(例えばペンジルオキシメチル基)、
トリチル基更にはアシル基(例えばアセチル基,p−ニ
トロベンゾイル基)が挙げられる.
本発明の(13又は([3式の光学活性アルコール及び
その保護体は、それぞれ下記一般式(m)又は下記一般
式(IV)
0X
で示される光学活性アルコールを酸化することにより得
ることができる.
この場合、酸化は(I[[], (rV)式の化合物を
必要に応じて保護し、この保護基がはずれない酸化法で
行なうことが好ましく、具体的にはスワン(Sworn
)酸化、コリンズ(Collins)酸化等の方法が好
適に採用される.なお、酸化条件に何ら制限はなく、通
常の条件とすることができる.更に、酸化終了後は、必
要に応じ、通常の方法で脱保護化することが望ましい.
なお、(III), (IV)式の光学活性アルコール
は、先に本出願人が特願昭83−57017号に提案し
た下記一般式
ープレス反応を行なうことによって得られる下記一般式
(Vl
0H
又は下記一般式(Vll
(式中、Ri, R”, R”li前記J同1llテL
6. )で示される光学活性エポキシアルコールを得、
これら光学活性エボキシアルコールをそれぞれ下記反応
式
(式中、R” R”,R’はそれぞれ炭素数1〜10
の置換もしくは未置換のアルキル基又は置換もしくは未
置換のフェニル基で、互いに同一であっても異なってい
てもよい.以下同様.)で示されるジアリルアルコール
に対して不斉シャ0H
0X
[11]
OX
(但し、R4は前記と同様である.)
のように誘導して合或することができる.上記(V)又
は[VI)から(Iff)又は(IV)へ誘導する場合
、まず(V)又は(Vl)の水酸基を常法により水酸基
の保護基Xで保護する.Xとしてはトリアルキルシリル
基(例えばトリメチルシリル基、t−プチルジメチルシ
リル基),アルコキシアルキル基(例えばメトキシメチ
ル基,エトキシエチル基),アラルキルオキシアルキル
基(例えばペンジルオキシメチル基)、トリチル基、更
にはテトラヒドロピラニル(THP)基等が挙げられる
が、次の脱シリル化条件に耐え易いという点でエトキシ
エチル基などのアルコキシアルキル基が好ましい.
次いで、エポキシ部の付け根のシリル基を常法により脱
シリル化する.通常はテトラn−プチルアンモニウムク
ロリドあるいはフフ化水素などフッ素系の化合物0.1
〜4当量を用い、溶媒としてジメチルスルホキシド(D
MSO).テトラヒドロフラン(THF)等を用いて反
応させる.これらは若干の水分を含んでも良く,また混
合して用いても良い.
更に、脱シリル化されたエボキシ化合物を水素化リチウ
ムアルミニウムなどの還元剤、あるいはジメチルマグネ
シウム,メチルリチウム,メチルマグネシウムクロリド
(グリニャール試薬),シメチル銅リチウムなどの有機
金属試剤で処理し、エポキシの開裂したアルコール化合
物(I[I]又は(IV)を得る.この反応も常法のエ
ポキシ開裂の反応条件で良い.但し、本発明の化合物の
場合基質中にオレフィン部分を含むので、大過剰の還元
剤を用いたり、強く加熱するなど過激な条件にするとオ
レフィン部分が飽和になる副反応が増すので極力穏和な
条件で行なうことが好ましい.通常は還元剤あるいは有
機金属試剤を脱シリル化された化合物に対して0.8〜
4当量用いれば良く、−80℃〜溶媒の還流温度でなる
べく穏和に反応させる.
本発明の(13, (II)式の光学活性アルコール及
び保護体は、(m〕,(IV)式の化合物を上記本発明
の方法で酸化して合成し、更に求核試剤を反応させると
、下記反応式のように選択的に化合物〔■〕,〔■】に
誘導することができる.(m)
(1)
0x
〔■〕
(IVI
(n)
C式中、R1は炭素数1〜10の置換もしくは未置換の
アルキル基又は置換もしくは未置換のフェ二ル基であり
、R4とRSは同一でないものである。)
ここで、求核試薬のR’MのR″は、水素原子、炭素数
l〜10の置換もしくは未置換のアルキル基,アルケニ
ル基,アルキニル基,又は置換もしくは未置換のフェニ
ル基を示し,またMは、それぞれLi,Na,K,Mg
,Ca,Ti,Zr,Ni,Cu,Zn,Ajl,Sn
より選ばれる金属又は該金属を含む基を示す.R’Mと
して具体的には,R’Li,R’MgBr,R’MHI
,(R’),CuQLi,,R’CuQLi,(R’)
,CuQLiMgBr,R’CuQMgBr等が挙げら
れる.但し、Qはハロゲン原子、シアノ基、アルキルチ
オ基、アリールチオ基又はチオシアノ基を示す.
上記求核試薬R’Mを化合物〔■〕又は(II)と反応
させるに際し、求核試薬R’Mは化合物に対し、0.5
〜4当量,特に0.8〜1.2当量用いることが好まし
い.
また、反応は溶媒を用いることができるが、反応に用い
られる溶媒としては反応を阻害しないものであればよく
、例えばテトラヒドロフラン、ヘキサン、ベンタン、ジ
エチルエーテル等が挙げられる.
なお、反応温度は通常−lOO〜50℃,好ましくは−
80〜O℃であり,反応時間は通常5分〜50時間であ
る.
この求核試薬R’Mと(I)または〔■〕式の光学活性
アルコールの反応は既に知られた通り立体選択的に進行
させることができる.即ち、(13又は(II)式中の
保護又は保護されていない水酸基とカルボニル基へのR
’Mの反応によって生じる水酸基の方向をsynあるい
はantiに制御できる.得られた化合物〔■〕,〔■
〕は、例えば下記反応式に示されるように、分子内に連
続する2つの不斉中心を有する2級アリルアルコールを
分子構造内に含むプロスタグランジンの合成中間体とし
て有用なω鎖に誘導される.
(式中、R@ , R’l , R@ , Rsは,そ
れぞれ炭素数1〜lOのアルキル基で、互に同一であっ
ても異なっていてもよい.)
具体的には、上記(IK3式で示される化合物の一例で
ある下記式
D〕
(X)
(XI)
CXI)
OSi(CH.).
の化合物は. N. Kolb等の方法によりメキシプ
ロスチル(M1xprost11)の合或に用いること
ができる(Tatrahedron Latt. 2
9 , 6 7 6 9 ,(1988)).
見豊魚亙果
以上説明したように,本発明の一般式(I)及び(II
)で示される光学活性を有するアルコール及びその保護
体は,新規な化合物であって、各種の生理活性物質、特
に分子内に連続する2つの不斉中心を有する2級アリル
アルコールを分子骨格中に含むプロスタグランジン等の
生瑞活性物質の合成中間体として有用であると共に、ア
ルコール自身が生理活性物質として作用するものである
.また、本発明の製造方法によれば、( 1 ),(I
I)式のγ位にシリル基を有する光学活性ケトアリルア
ルコール及びその保護体を高い光学純度と高い安定性を
もって任意に.選択性よく合或することができる.
以下、実施例及び参考例を示して本発明を具体的に説明
するが、本発明は下記実施例に制限されるものではない
.
なお、各例においてMeはメチル基、n−Buはn−ブ
チル基を示す.
〔参考例1〕
三
〇H
2)
水冷下、化合物(1)(6.44g,26.4mmal
l)の塩化メチレン(50d)溶液にエチルビニルエー
テル(5.05d,52.8mmol)及びビリジウム
p−トルエンスルホン酸(約300q)を加えた.室温
に昇温し、約4時間撹拌した後、飽和NaHCO,水溶
液(150d)を加えた.有機層を分液し、水層をヘキ
サン(50d)で抽出し、得られた有機層をM g S
O4で乾燥した.?7t過後、炉液の溶媒を減圧下留
去して化合物(2)の粗生成物8.4 7 gを得た.
このまま次の反応に用いた.
化合物(2)の粗生戒物(8.4 7 g)をジメチル
スルホキシド(50id)に溶解し、室温でn一Bu4
NF(34.8ml,THF中1モル溶液,34.8m
mall)を加えた.室温で12時間撹拌した後,飽和
食塩水溶液(150d)を加え、ヘキサン(2X100
d)で抽出した.有機層をMgSO,で乾燥し、炉過後
、炉液を減圧下留去し,化合物(3)の粗生成物(約9
g)を得た.シリカゲル力ラムクロマトグラフィーによ
り精製し、化合物(3) (5.4 8 g , 2
2.4mmoffi)を収率85%で得た.
〔参考例2〕
(3) (4)アル
ゴン雰囲気下,乾燥テトラヒドロフラン(THF)にL
IAIH. (4 3 4 N, 1 1 .4mmo
Jl)を加えてO℃に冷却後、化合物(3)・(2.7
8g,1 1 . 4 wmofi)のTHF (10
all)溶液をゆっくり滴下した.30分間撹拌後、O
℃で水(約0.7−)をゆっくり加えた.続いてNa
F (6 g)とセライト(6g)を順に加え、室温で
30分間撹拌した.m液をセライトで炉過し,rp液を
減圧下で潰縮したところ,化合物(4) (2.7 8
g ,収率〜100%)が得られた.
(実施例1)
アルゴン雰囲気下、−60℃でCH.(J,(30d)
にシュウ酸塩化物(0.9 6m, 1 0.9mmo
ffi)を加え,撹拌しなからジメチルスルホキシド(
1 − 5 6 d,2 1 − 9gtmoJl)を
ゆっくり滴下した.5分間撹拌後、参考例2で得られた
化合物(4)(1.35g,5.49mmon)のCH
.Cわ(10d)溶液を滴下し、15分間撹拌した.次
に,−60℃でトリエチノレアミン(6,llIl!,
44■won)を滴下し、撹拌しなからl時間かけて0
℃に昇温した.飽和食塩水(50d)を加え、ヘキサン
(40d)で2回抽出後、有機層をMgSO,で乾燥し
た.rp過後,rp液の溶媒を減圧下に留去して得られ
る粗生成物をヘキサン(40+all)に溶解したとこ
ろ、少量の沈殿が生じた.更に、少量のシリカゲルを用
いて炉過し,沈殿を除いた後、炉液の溶媒を減圧下で留
去したところ、ほぼ純粋な化合物(5) (1.3 2
g,収率99%)が得られた.なお、この化合物〈5
)はこのまま次の反応に用いた.
化合物(5)の特性値は以下の通りであった.”HNM
R (CCI,,PRH):
60.14 (s, 9H), 0.98−1.40
(w+, 68), 2.00(ss, 3H), 3
.15−3.90 (j 2}1),4.19及び4.
35 (Zd, J=4.0Hz及びJ=3.8Hz,
IH),5.57−6.23 (m,2H)I R
(neat) :
2950, 1710, 1240, 1080, 5
03−’R f =0.47及び0.52 (ヘキサン
/エーテル=2/1.2種のジアステレオマー混合物)
〔参考例3〕
アルゴン雰囲気下, n − BuMgBr ( 5
. 7 aQ,THF中1.05N溶液, 5.9 7
mmojl)にTHF(5−)を加えて−78℃に冷却
し,−78℃で化合物(5)(9 7 01113.9
8mmon)のTHF(6−)溶液をゆっくり滴下し
た.更に、−78℃のままで30分間撹拌した後、約1
.5時間かけてO℃に昇温した.飽和食塩水(30d)
,飽和NH,Ct水溶液(10d)を加えた後,ヘキサ
ン(20d)で2回抽出した.得られた有機層をMgS
O,で乾燥後,tp過し、炉液の溶媒を減圧下で留去し
たところ、化合物(6)(1.0g,3.29msio
JI)の粗生成物を収率83%で得た.〔参考例4〕
(5)
(6)
OH
アルゴン雰囲気下、化合物(6)(1,OOg,3 .
2 9 mgioffi)のTHF (10mQ)溶
液を0℃に冷却し、NaH (パラフィンを洗浄除去し
たもの,1 5 8 mg, 6 . 5 8mmon
)を加えた後、ヨー化メチル(0 . 3 1 mjn
, 4 . 9 4mmall)を加え,室温で12時
間撹拌した.次に,飽和食塩水(20d)を加え、ヘキ
サン(30d)で抽出後、得られた有機層をMgS04
で乾燥した.炉過後、炉液の溶媒を減圧下で留去したと
ころ、化合物(7)(1.0 2 g)が得られた.次
いで、この化合物(7)をメタノール(20d)に溶解
し、p一トルエンスルホン酸(〜30■)を加え,室温
で30分間撹拌した後,飽和NaHCO,水溶液(40
d)を加え、ヘキサン(20d)で2回抽出した,得ら
れた有機層をMgSO4で乾燥後、炉過し、炉液の溶媒
を減圧下で留去したところ、化合物(8)の粗生成物が
得られた.これをシリカゲル力ラムクロマトグラフィー
により精製したところ、化合物(8)(650■, 2
. 83msall)が収率86%(2段階)で得られ
た.
化合物(8)の特性値は以下の通りであった.”HNM
R (CCL,PhH):
δ0,13 (s, 9H), 0.96 (t, J
=6.6Hz, 3H),1.03 (s, 3H),
1.15−1.74 (+*, 6H), 2.33
(brg, LH), 3.17 (s, 3H),
3.94 (tt J=1.8Hz, II{), 5
.78−6.02 (m, 2H)”CNMR (CD
CJI.):
δ143.7, 132.3. 7g.9, 77.2
, 48.9, 33.3,24,8, 23.1,
17,6, 13J, −1.5I R (neat)
:
345G. 2950, 1620, 1250, 8
40cs−”( α) F : +26−4 (c 1
−5L C H Cら)m p . : 31.5−
−32.0℃(針状晶)〔参考例5〕
化合物(8) <24 0111:− 0.9 8ms
*ojl)のCH.CD.溶液(5d)にt−プチルハ
イド口ベルオキシド(5.07M,CH,CI!,溶液
,0.39d,1.96mmojl)と酸化バナジウム
アセチルアセトナート(V O (acac)a)(
1 0 mg)を加えた後,室温で3時間撹拌した.こ
の混合物に更にV O (acac),(10mg)を
追加し、5時間撹拌し,次にジメチルスルフィド(0.
5d)を添加し、1時間撹拌した。N a H C O
s水溶液(20d)とヘキサン(30mQ)を加え、
有II&層を分離し、また、水層をヘキサン(20d)
で抽出した。これら有機層をMgSO4で乾燥させ、濃
縮し、得られた粗精製物をシリカゲJレ力ラムクロマト
グラフィーにかけたところ、化合物(9)(225■,
0.865問oOが収率88%で得られた.
得られた化合物(9)の特性値は以下の通りであった。Furthermore, as mentioned above, R4 represents a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or a substituted or unsubstituted phenyl group, and specifically, R4 represents methyl, ethyl, n
-propyl, i-propyl, n-butyl, i-butyl,
t-butyl, amyl, hexyl, heptyl, octyl,
nonyl, decyl, 2-methylhexyl, 2-methyl-2
-hexyl, 2-hexyl, cyclopentyl, cyclohexyl, cyclohexylmethyl, hexyl-4-yl-2
-yl, hebut-4-yn-2-yl, 2,6-dimethyl-hebut-5-en-1-yl, pent-1-en-1-yl, pent-2-en-1-yl, hexer-1-yl
En-2-yl, 3-ethoxy-2-methyl-propan-2-yl, ethoxyethyl, 5-methoxyhexyl,
6-methoxy-2-hexyl, methyl halide, n-butyl halide, n-pentyl halide, nonyl halide, phenyl, benzyl, phenyl halide,
n-pentyloxymethyl, 1-ethoxy-2-methyl-propan-2-yl, phenoxymethyl, pendyloxymethyl, p-chlorophenoxymethyl, 2-phenylethyl, pendyloxyethyl, p-fluorophenoxy Methyl, phenylacetylenyl, m-chlorophenoxymethyl. Mention groups such as m-trifluoromethyl-phenoxymethyl, l-butyl-cycloprobyl, 3-ethyl-cyclopentyl, penzothiophen-5-yl, 2-octenyl, 3-methoxycarbonylprobyl, vinyl, etc. Can be done. Further, X is a hydrogen atom or a hydroxyl group protecting group, and examples of the hydroxyl group protecting group include a trialkylsilyl group (e.g. trimethylsilyl group, t-butyldimethylsilyl group, phenyldimethylsilyl group),
Alkoxyalkyl groups (e.g. methoxymethyl group, ethoxyethyl group, 2-tetrahydropyranyl group), aralkyloxyalkyl groups (e.g. penzyloxymethyl group),
Trityl groups and further acyl groups (eg, acetyl groups, p-nitrobenzoyl groups) can be mentioned. The optically active alcohol of formula (13 or ([3) and its protected form can be obtained by oxidizing the optically active alcohol represented by the following general formula (m) or the following general formula (IV) 0X, respectively. In this case, the oxidation is preferably performed by an oxidation method in which the compound of the formula (I[[], (rV)) is protected as necessary and this protecting group is not removed.
) oxidation, Collins oxidation, etc. are preferably employed. Note that there are no restrictions on the oxidation conditions, and normal conditions can be used. Furthermore, after the oxidation is complete, it is desirable to deprotect by a conventional method, if necessary. The optically active alcohols of formulas (III) and (IV) can be expressed by the following general formula (Vl 0H or The following general formula (Vll (wherein, Ri, R'', R''li)
6. ) to obtain an optically active epoxy alcohol,
These optically active epoxy alcohols are each expressed by the following reaction formula (in the formula, R"R" and R' each have a carbon number of 1 to 10
are substituted or unsubstituted alkyl groups or substituted or unsubstituted phenyl groups, which may be the same or different from each other. Same below. ) can be induced and combined into the asymmetric form 0H 0X [11] OX (where R4 is the same as above). When deriving (Iff) or (IV) from the above (V) or [VI), first the hydroxyl group of (V) or (Vl) is protected with a hydroxyl-protecting group X by a conventional method. X is a trialkylsilyl group (e.g. trimethylsilyl group, t-butyldimethylsilyl group), an alkoxyalkyl group (e.g. methoxymethyl group, ethoxyethyl group), an aralkyloxyalkyl group (e.g. penzyloxymethyl group), a trityl group, Further examples include a tetrahydropyranyl (THP) group, but an alkoxyalkyl group such as an ethoxyethyl group is preferred because it can easily withstand the following desilylation conditions. Next, the silyl group at the base of the epoxy part is desilylated using a conventional method. Usually 0.1 fluorine-based compounds such as tetra-n-butylammonium chloride or hydrogen fluoride
~4 equivalents and dimethyl sulfoxide (D
MSO). React using tetrahydrofuran (THF) or the like. These may contain some moisture or may be used in combination. Furthermore, the desilylated epoxy compound is treated with a reducing agent such as lithium aluminum hydride, or an organometallic reagent such as dimethylmagnesium, methyllithium, methylmagnesium chloride (Grignard reagent), dimethylcopperlithium, etc., to induce cleavage of the epoxy. An alcohol compound (I [I] or (IV) is obtained. This reaction may also be carried out under the reaction conditions of conventional epoxy cleavage. However, in the case of the compound of the present invention, since the substrate contains an olefin moiety, a large excess of the reducing agent is used. It is preferable to carry out the process under as mild conditions as possible, as extreme conditions such as using or strongly heating increase the side reaction that saturates the olefin moiety.Usually, reducing agents or organometallic reagents are added to the desilylated compound. 0.8~
It is sufficient to use 4 equivalents, and the reaction is carried out as mildly as possible at -80°C to the reflux temperature of the solvent. The optically active alcohol and protected form of formula (13, (II)) of the present invention can be synthesized by oxidizing the compound of formula (m), (IV) by the method of the present invention, and further reacting with a nucleophilic reagent. , can be selectively induced into compounds [■], [■] as shown in the following reaction formula. (m) (1) 0x [■] (IVI (n) C In the formula, R1 has 1 to 1 carbon atoms. 10 substituted or unsubstituted alkyl groups or substituted or unsubstituted phenyl groups, and R4 and RS are not the same.) Here, R'' of R'M of the nucleophile is a hydrogen atom. , represents a substituted or unsubstituted alkyl group, alkenyl group, alkynyl group, or substituted or unsubstituted phenyl group having 1 to 10 carbon atoms, and M is Li, Na, K, Mg, respectively.
, Ca, Ti, Zr, Ni, Cu, Zn, Ajl, Sn
Indicates a metal selected from or a group containing the metal. Specifically, as R'M, R'Li, R'MgBr, R'MHI
,(R'),CuQLi,,R'CuQLi,(R')
, CuQLiMgBr, R'CuQMgBr, etc. However, Q represents a halogen atom, a cyano group, an alkylthio group, an arylthio group, or a thiocyano group. When reacting the above nucleophile R'M with compound [■] or (II), the nucleophile R'M is 0.5
It is preferable to use ~4 equivalents, particularly 0.8 to 1.2 equivalents. Further, a solvent can be used in the reaction, but any solvent used in the reaction may be one that does not inhibit the reaction, and examples thereof include tetrahydrofuran, hexane, bentane, diethyl ether, and the like. Note that the reaction temperature is usually -100 to 50°C, preferably -
The temperature is 80 to 0°C, and the reaction time is usually 5 minutes to 50 hours. As is already known, the reaction between the nucleophile R'M and the optically active alcohol of formula (I) or [■] can proceed stereoselectively. That is, R to the protected or unprotected hydroxyl group and carbonyl group in formula (13 or (II))
'The direction of the hydroxyl group produced by the reaction of M can be controlled to syn or anti. Obtained compounds [■], [■
] is induced into an ω chain that is useful as a synthetic intermediate for prostaglandin, which contains a secondary allyl alcohol having two consecutive asymmetric centers in its molecular structure, as shown in the reaction formula below. Ru. (In the formula, R@, R'l, R@, and Rs are each an alkyl group having 1 to 10 carbon atoms, and may be the same or different.) Specifically, the above (IK3 The following formula D is an example of a compound represented by the formula: (X) (XI) CXI) OSi(CH.). The compound is . N. It can be used in combination with mexiprostil (M1xprost11) by the method of Kolb et al. (Tatrahedron Latt. 2).
9, 6769, (1988)). As explained above, the general formulas (I) and (II) of the present invention
) and its protected forms are novel compounds containing various physiologically active substances, especially secondary allyl alcohols having two consecutive asymmetric centers in the molecule. Alcohol is useful as a synthetic intermediate for bioactive substances such as prostaglandins, and alcohol itself acts as a physiologically active substance. Moreover, according to the manufacturing method of the present invention, (1), (I
I) An optically active ketoallyl alcohol having a silyl group at the γ-position of the formula and its protected form can be optionally prepared with high optical purity and high stability. It can be combined with good selectivity. The present invention will be specifically explained below with reference to Examples and Reference Examples, but the present invention is not limited to the Examples below. In each example, Me represents a methyl group and n-Bu represents an n-butyl group. [Reference Example 1] 30H 2) Under water cooling, compound (1) (6.44 g, 26.4 mmal
Ethyl vinyl ether (5.05 d, 52.8 mmol) and viridium p-toluenesulfonic acid (approximately 300 q) were added to a solution of 1) in methylene chloride (50 d). After raising the temperature to room temperature and stirring for about 4 hours, saturated NaHCO, aqueous solution (150 d) was added. The organic layer was separated, the aqueous layer was extracted with hexane (50d), and the obtained organic layer was extracted with M g S
Dry with O4. ? After 7 tons had passed, the solvent in the furnace liquid was distilled off under reduced pressure to obtain 8.47 g of a crude product of compound (2).
This was used as is for the next reaction. The crude compound (2) (8.47 g) was dissolved in dimethyl sulfoxide (50id), and n-Bu4 was dissolved at room temperature.
NF (34.8 ml, 1 molar solution in THF, 34.8 m
mall) was added. After stirring at room temperature for 12 hours, saturated brine solution (150d) was added, and hexane (2X100
Extracted in step d). The organic layer was dried with MgSO, and after passing through the oven, the oven solution was distilled off under reduced pressure to obtain the crude product of compound (3) (approximately 9
g) was obtained. Purified by silica gel column chromatography to obtain compound (3) (5.48 g, 2
2.4 mmoffi) was obtained in a yield of 85%. [Reference Example 2] (3) (4) Under an argon atmosphere, add L to dry tetrahydrofuran (THF).
IAIH. (4 3 4 N, 1 1.4 mmo
After adding Jl) and cooling to O℃, compound (3)・(2.7
8g, 1 1. 4 wmofi) of THF (10
all) solution was slowly added dropwise. After stirring for 30 minutes, O
Water (approximately 0.7°C) was slowly added at ℃. followed by Na
F (6 g) and Celite (6 g) were added in order, and the mixture was stirred at room temperature for 30 minutes. When the m solution was filtered through Celite and the rp solution was collapsed under reduced pressure, compound (4) (2.7 8
g, yield ~100%) was obtained. (Example 1) CH. (J, (30d)
Oxalate chloride (0.96m, 10.9mmo
ffi) and, without stirring, add dimethyl sulfoxide (
1-56d, 21-9gtmoJl) was slowly added dropwise. After stirring for 5 minutes, CH of compound (4) (1.35 g, 5.49 mmon) obtained in Reference Example 2
.. C. (10d) solution was added dropwise and stirred for 15 minutes. Next, triethynoleamine (6,llIl!,
44 ■ won) was added dropwise and the temperature was reduced to zero over 1 hour without stirring.
The temperature was raised to ℃. After adding saturated brine (50d) and extracting twice with hexane (40d), the organic layer was dried over MgSO. After the RP filtration, the solvent of the RP liquid was distilled off under reduced pressure and the resulting crude product was dissolved in hexane (40+all), and a small amount of precipitate was generated. Furthermore, after filtering in a furnace using a small amount of silica gel to remove the precipitate, the solvent in the furnace liquid was distilled off under reduced pressure, and almost pure compound (5) (1.3 2
g, yield 99%) was obtained. In addition, this compound <5
) was used as is in the next reaction. The characteristic values of compound (5) were as follows. “HNM
R (CCI,,PRH): 60.14 (s, 9H), 0.98-1.40
(w+, 68), 2.00(ss, 3H), 3
.. 15-3.90 (j 2}1), 4.19 and 4.
35 (Zd, J=4.0Hz and J=3.8Hz,
IH), 5.57-6.23 (m, 2H) I R
(neat): 2950, 1710, 1240, 1080, 5
03-'R f =0.47 and 0.52 (hexane/ether = 2/1.2 diastereomer mixture)
[Reference Example 3] In an argon atmosphere, n-BuMgBr (5
.. 7 aQ, 1.05N solution in THF, 5.9 7
THF (5-) was added to mmojl), cooled to -78°C, and compound (5) (9 7 01113.9
A THF (6-) solution of 8 mmon) was slowly added dropwise. Furthermore, after stirring for 30 minutes at -78°C, about 1
.. The temperature was raised to 0°C over 5 hours. Saturated salt solution (30d)
, saturated NH, Ct aqueous solution (10d) was added, and then extracted twice with hexane (20d). The obtained organic layer was mixed with MgS
After drying at
The crude product of JI) was obtained in a yield of 83%. [Reference Example 4] (5) (6) OH Under an argon atmosphere, compound (6) (1,OOg,3.
A solution of 29 mgioffi) in THF (10 mQ) was cooled to 0°C, and a solution of NaH (paraffin-free, 158 mg, 6.58 mmon) was cooled to 0°C.
), then methyl iodide (0.31 mjn
, 4. 94 mmall) was added thereto, and the mixture was stirred at room temperature for 12 hours. Next, saturated brine (20d) was added, and after extraction with hexane (30d), the resulting organic layer was MgSO4
It was dried. After passing through the furnace, the solvent in the furnace solution was distilled off under reduced pressure to obtain compound (7) (1.0 2 g). Next, this compound (7) was dissolved in methanol (20d), p-toluenesulfonic acid (~30d) was added, and after stirring at room temperature for 30 minutes, saturated NaHCO, aqueous solution (40d) was added.
d) was added and extracted twice with hexane (20d). The obtained organic layer was dried with MgSO4, filtered, and the solvent of the furnace solution was distilled off under reduced pressure, resulting in the crude product of compound (8). I got something. When this was purified by silica gel column chromatography, compound (8) (650, 2
.. 83msall) was obtained in a yield of 86% (2 steps). The characteristic values of compound (8) were as follows. “HNM
R (CCL, PhH): δ0,13 (s, 9H), 0.96 (t, J
=6.6Hz, 3H), 1.03 (s, 3H),
1.15-1.74 (+*, 6H), 2.33
(brg, LH), 3.17 (s, 3H),
3.94 (tt J=1.8Hz, II{), 5
.. 78-6.02 (m, 2H)”CNMR (CD
C.J.I. ): δ143.7, 132.3. 7g. 9, 77.2
, 48.9, 33.3, 24, 8, 23.1,
17,6, 13J, -1.5I R (neat)
: 345G. 2950, 1620, 1250, 8
40cs-” (α) F: +26-4 (c 1
-5L C H C et al) m p . : 31.5-
-32.0°C (acicular crystals) [Reference Example 5] Compound (8) <24 0111: - 0.9 8ms
*ojl) CH. CD. Solution (5d) contains t-butylhydride peroxide (5.07M, CH, CI!, solution, 0.39d, 1.96 mmojl) and vanadium oxide acetylacetonate (V O (acac)a) (
After adding 10 mg), the mixture was stirred at room temperature for 3 hours. Additional V O (acac), (10 mg) was added to this mixture and stirred for 5 hours, then dimethyl sulfide (0.
5d) was added and stirred for 1 hour. N a H C O
Add s aqueous solution (20d) and hexane (30mQ),
Separate the layers and add the aqueous layer to hexane (20d)
Extracted with. These organic layers were dried with MgSO4 and concentrated, and the resulting crude product was subjected to silicage gel column chromatography. Compound (9) (225
0.865 oO was obtained with a yield of 88%. The characteristic values of the obtained compound (9) were as follows.
’HNMR (CCゑ,,PhH):
60.12 (s, 9N), 0.98 (tt J
−6.0Hz, 3H),1.21 (s, 3H),
1.17−1.82 (+a, 6H), 2.09
及び2.11 (2d, J=3.6}1z及びJ=3
.6Hz, LH)−2.37 (brs, LH),
2.72及び2.86 (dd, J=3.6,6.
0Hz及びJ=3.6, 6.0Hz, IH), 3
.12−3.40(m, IH), 3.19 (s,
3H)I R (neat):
3440,2950,1460,1380,1250,
1070.815am−1
R f : 0.22及び0.11 (ヘキサン/Et
20= 3 / l ,ジアステレオマー混合物)
〔参考例6〕
(9)
(10)
化合物(9) (220g, 0.846mmoffi
)のTHF溶液(3d)にLDA (ジイソプ口ピルア
ミン(0.4 7d, 3.3 8mmall)とn−
ブチルリチウム(n−BuLi)(1.1d, ヘキサ
ン中2.31モル溶液, 2.54mmoffi)とか
ら調製〕のTHF溶液(3d)を0℃で加えた.10分
後,この混合物にn−Bu3SnH (0.2 7m,
1.0 2mmon)を加え、室温まで加温し、更に3
時間撹拌した.食塩水(20d)とヘキサン(20d)
を加え,有機溜を分離し、また、水層をヘキサン(20
d)で抽出した.これら有機層をM g S O 4で
乾燥し、濃縮し、得られた粗精製物をシリカゲル力ラム
クロマトグラフィーにかけたところ、化合物(10)(
348■, 0.755ms+offi)が収率89%
で得られた.
化合物(10)の特性値は以下の通りであった.’HN
R (C(J,,Me4Si):60.40−2.00
(m,39H),2.18 (d,J=3.0H
z),3.17 (s, 3H), 3.96 (dd
, J=3.0, 5.4Hz,IH), 5.92
(dd, J=5.4. 21Hz, IH), 6.
16 (d,J=21Hz, IH)
”CNMR (CDCれ):
δ146.2, 130.8, 78.9, 78.0
, 4B.7, 33.2,21S.9, 27.0,
24.8, 23.1, 17.4, 13.8,
13.4,9.3
I R (neat) : 3450, 2930
, 1465, 1380.10703−’
?α〕■+14.6”
(c 2.01,
CHC囚,)'HNMR (CC,, PhH): 60.12 (s, 9N), 0.98 (tt J
-6.0Hz, 3H), 1.21 (s, 3H),
1.17-1.82 (+a, 6H), 2.09
and 2.11 (2d, J=3.6}1z and J=3
.. 6Hz, LH) -2.37 (brs, LH),
2.72 and 2.86 (dd, J=3.6,6.
0Hz and J=3.6, 6.0Hz, IH), 3
.. 12-3.40 (m, IH), 3.19 (s,
3H) I R (neat): 3440, 2950, 1460, 1380, 1250,
1070.815am-1 R f : 0.22 and 0.11 (hexane/Et
20=3/l, diastereomer mixture) [Reference Example 6] (9) (10) Compound (9) (220g, 0.846mmoffi
) in THF solution (3d) with LDA (diisopropylamine (0.47d, 3.38mmall) and n-
A THF solution (3d) of butyllithium (n-BuLi) (1.1d, 2.31 molar solution in hexane, 2.54 mmoffi) was added at 0°C. After 10 minutes, n-Bu3SnH (0.2 7m,
Add 1.0 2 mmon), warm to room temperature, and add 3
Stir for hours. Salt solution (20d) and hexane (20d)
was added to separate the organic fraction, and the aqueous layer was diluted with hexane (20
Extracted in step d). These organic layers were dried with MgSO4 and concentrated, and the resulting crude product was subjected to silica gel force column chromatography, resulting in compound (10) (
348■, 0.755ms+offi) with a yield of 89%
Obtained with. The characteristic values of compound (10) were as follows. 'HN
R(C(J,,Me4Si):60.40-2.00
(m, 39H), 2.18 (d, J=3.0H
z), 3.17 (s, 3H), 3.96 (dd
, J=3.0, 5.4Hz, IH), 5.92
(dd, J=5.4.21Hz, IH), 6.
16 (d, J=21Hz, IH) CNMR (CDC): δ146.2, 130.8, 78.9, 78.0
, 4B. 7, 33.2, 21S. 9, 27.0,
24.8, 23.1, 17.4, 13.8,
13.4, 9.3 I R (neat): 3450, 2930
, 1465, 1380.10703-'? α〕■+14.6” (c 2.01, CHC prisoner,)
Claims (1)
10の置換もしくは未置換のアルキル基又は置換もしく
は未置換のフェニル基で、互いに同一であっても異なっ
ていてもよく、R^4は炭素数1〜10の置換もしくは
未置換のアルキル基又は置換もしくは未置換のフェニル
基であり、Xは水素原子又は水酸基の保護基である。) で示されるγ位にシリル基を有する光学活性アルコール
類。 2、下記一般式〔III〕 ▲数式、化学式、表等があります▼・・・・〔III〕 又は下記一般式〔IV〕 ▲数式、化学式、表等があります▼・・・・〔IV〕 (式中、R^1、R^2、R^3はそれぞれ炭素数1〜
10の置換もしくは未置換のアルキル基又は置換もしく
は未置換のフェニル基で、互いに同一であっても異なっ
ていてもよく、R^4は炭素数1〜10の置換もしくは
未置換のアルキル基又は置換もしくは未置換のフェニル
基であり、Xは水素原子又は水酸基の保護基である。) で示される光学活性アルコールを酸化することを特徴と
する下記一般式〔 I 〕 ▲数式、化学式、表等があります▼・・・・〔 I 〕 又は下記一般式〔II〕 ▲数式、化学式、表等があります▼・・・・〔II〕 (但し、式中のR^1、R^2、R^3、R^4、Xは
それぞれ前記と同様である。) で示されるγ位にシリル基を有する光学活性アルコール
類の製造方法。[Claims] 1. The following general formula [I] ▲There are mathematical formulas, chemical formulas, tables, etc.▼...[I] and the following general formula [II] ▲There are mathematical formulas, chemical formulas, tables, etc.▼... ...[II] (In the formula, R^1, R^2, and R^3 each have 1 to 1 carbon atoms
10 substituted or unsubstituted alkyl groups or substituted or unsubstituted phenyl groups, which may be the same or different from each other, and R^4 is a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or a substituted or an unsubstituted phenyl group, and X is a hydrogen atom or a hydroxyl group-protecting group. ) An optically active alcohol having a silyl group at the γ-position. 2. The following general formula [III] ▲There are mathematical formulas, chemical formulas, tables, etc.▼...[III] Or the following general formula [IV] ▲There are mathematical formulas, chemical formulas, tables, etc.▼...[IV] ( In the formula, R^1, R^2, and R^3 each have a carbon number of 1 to
10 substituted or unsubstituted alkyl groups or substituted or unsubstituted phenyl groups, which may be the same or different from each other, and R^4 is a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms or a substituted or an unsubstituted phenyl group, and X is a hydrogen atom or a hydroxyl group-protecting group. ) The following general formula [I] ▲There are mathematical formulas, chemical formulas, tables, etc.▼...[I] or the following general formula [II] ▲Mathematical formulas, chemical formulas, tables, etc. There are tables, etc. ▼... [II] (However, R^1, R^2, R^3, R^4, and X in the formula are each the same as above.) At the γ position shown by A method for producing an optically active alcohol having a silyl group.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1245956A JP2896584B2 (en) | 1989-09-20 | 1989-09-20 | Optically active keto alcohol having silyl group at γ-position and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1245956A JP2896584B2 (en) | 1989-09-20 | 1989-09-20 | Optically active keto alcohol having silyl group at γ-position and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH03106887A true JPH03106887A (en) | 1991-05-07 |
JP2896584B2 JP2896584B2 (en) | 1999-05-31 |
Family
ID=17141351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1245956A Expired - Lifetime JP2896584B2 (en) | 1989-09-20 | 1989-09-20 | Optically active keto alcohol having silyl group at γ-position and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2896584B2 (en) |
-
1989
- 1989-09-20 JP JP1245956A patent/JP2896584B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2896584B2 (en) | 1999-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1201712A (en) | Carbacyclin analogs | |
JP2007538041A (en) | Method for producing diphenylazetidinone derivative | |
JPH03106887A (en) | Optically active alcohols and production thereof | |
US4767853A (en) | Synthesis of 1-(allyloxycarbonyl)-methyl-3-(hydroxyethyl)-4-beta-naphthoxythiocarbonylthio-2-azetidinones and hydroxy protected analogs thereof | |
JPH0940684A (en) | New phosphine-phosphinite compound and production of 4-((r)-1'-formylethyl)azetidin-2-one derivative | |
DE3728801A1 (en) | (2-PHENYLPROPAN-2-YL) SILANE COMPOUNDS AND A METHOD FOR THE PRODUCTION THEREOF | |
US4948885A (en) | Synthesis of azetidinones | |
JP3446225B2 (en) | Cyclopentane derivative and method for producing the same | |
US5053502A (en) | Anhydro penicillin derivatives | |
JPH025745B2 (en) | ||
JPH08325226A (en) | Production of vitamin d3 derivative | |
JP2905024B2 (en) | Method for producing optically active 6- (4-substituted inden-1-yl) -2-methyl-3-heptanols | |
JPH07233175A (en) | Asymmetric production of metal-substituted cyclopropylmethanol derivative. | |
US5075438A (en) | Synthesis of azetidinones | |
JP2507519B2 (en) | Diastereoselective preparation of 3-substituted-1-cyclopentenol derivatives | |
JP3403761B2 (en) | 3,5-Dihydroxy-1-octen-7-ynes and method for producing the same | |
JPS5944336A (en) | Novel preparation of 2-allylcyclopentanones | |
JP2737214B2 (en) | Method for producing 4-hydroxy-2-cyclopentenone derivative | |
KR100201564B1 (en) | Azetidinone compound and their preparation method | |
US4876338A (en) | Synthesis of azetidinones using CuCl | |
JP2848937B2 (en) | Process for producing substituted methylenecyclopentanes | |
JPH0395189A (en) | Optically active alcohol and its production | |
JPH0474152A (en) | Production of alpha,beta-substituted cyclopentanone derivative | |
JPH0210149B2 (en) | ||
JPH01228936A (en) | Production of alpha-allylated cyclopentanone derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090312 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090312 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100312 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100312 Year of fee payment: 11 |